Angel et al., 2012 - Google Patents
Mass spectrometry-based proteomics: existing capabilities and future directionsAngel et al., 2012
View PDF- Document ID
- 6600273861139194732
- Author
- Angel T
- Aryal U
- Hengel S
- Baker E
- Kelly R
- Robinson E
- Smith R
- Publication year
- Publication venue
- Chemical Society Reviews
External Links
Snippet
Mass spectrometry (MS)-based proteomics is emerging as a broadly effective means for identification, characterization, and quantification of proteins that are integral components of the processes essential for life. Characterization of proteins at the proteome and sub …
- 238000000575 proteomic 0 title abstract description 53
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or superfluid chromatograph
-
- H—ELECTRICITY
- H01—BASIC ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometer or separator tubes
- H01J49/02—Details
- H01J49/04—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components
-
- H—ELECTRICITY
- H01—BASIC ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometer or separator tubes
- H01J49/004—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn
- H01J49/0045—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn characterised by the fragmentation or other specific reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2458/00—Labels used in chemical analysis of biological material
-
- H—ELECTRICITY
- H01—BASIC ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometer or separator tubes
- H01J49/0027—Methods for using particle spectrometers
- H01J49/0031—Step by step routines describing the use of the apparatus
-
- H—ELECTRICITY
- H01—BASIC ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometer or separator tubes
- H01J49/02—Details
- H01J49/10—Ion sources; Ion guns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Angel et al. | Mass spectrometry-based proteomics: existing capabilities and future directions | |
Rozanova et al. | Quantitative mass spectrometry-based proteomics: an overview | |
Zimmer et al. | Advances in proteomics data analysis and display using an accurate mass and time tag approach | |
Garcia | What does the future hold for top down mass spectrometry? | |
Steen et al. | The ABC's (and XYZ's) of peptide sequencing | |
Zhang et al. | Overview of peptide and protein analysis by mass spectrometry | |
US10852306B2 (en) | Gas-phase purification for accurate isobaric tag-based quantification | |
Zhang et al. | Application of electron transfer dissociation mass spectrometry in analyses of non‐enzymatically glycated peptides | |
Révész et al. | Collision energies: Optimization strategies for bottom‐up proteomics | |
Kolli et al. | Engaging challenges in glycoproteomics: recent advances in MS-based glycopeptide analysis | |
Zhao et al. | Evolution of mass spectrometry instruments and techniques for blood proteomics | |
WO2007144606A2 (en) | Mass spectrometry biomarker assay | |
Gao et al. | Protein analysis by shotgun proteomics | |
EP2021805A2 (en) | Expression quantification using mass spectrometry | |
Chicooree et al. | The application of targeted mass spectrometry‐based strategies to the detection and localization of post‐translational modifications | |
EP2162748A2 (en) | Expression quantification using mass spectrometry | |
Baba et al. | Localization of multiple O-linked glycans exhibited in isomeric glycopeptides by hot electron capture dissociation | |
Zhang et al. | FT-ICR mass spectrometry in the drug discovery process | |
EP3287788B1 (en) | Methods for mass spectrometry-based quantification using labelled compounds | |
Liang et al. | Quantitation of protein post-translational modifications using isobaric tandem mass tags | |
Peltoniemi et al. | Novel data analysis tool for semiquantitative LC-MS-MS2 profiling of N-glycans | |
JP7668411B2 (en) | Automated sample workflow for LC-MS-based HbA1c measurement at the intact protein level | |
Mesmin et al. | Complexity reduction of clinical samples for routine mass spectrometric analysis | |
Nanni et al. | Mass spectrometry in proteomics: Technologies, methods, and research applications for the life sciences | |
Niu et al. | Determination of monoisotopic masses of chimera spectra from high‐resolution mass spectrometric data by use of isotopic peak intensity ratio modeling |